کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8738506 | 1591728 | 2018 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
ترجمه فارسی عنوان
نظارت بر فعالیت تیگیکایکلین در برابر جدایی های بالینی از مجموعه های جهانی (آمریکای شمالی، اروپا، آمریکای لاتین و آسیا و اقیانوس آرام) (2016)
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
میکروبیولوژی و بیوتکنولوژی کاربردی
چکیده انگلیسی
Tigecycline and comparators were tested by the reference broth microdilution method against 33 348 non-duplicate bacterial isolates collected prospectively in 2016 from medical centres in the Asia-Pacific (3443 isolates), Europe (13 530 isolates), Latin America (3327 isolates) and the USA (13 048 isolates). Among 7098 Staphylococcus aureus isolates tested, >99.9% were inhibited by â¤0.5âmg/L tigecycline (MIC50/90, 0.06/0.12âmg/L), including >99.9% of methicillin-resistant S. aureus and 100.0% of methicillin-susceptible S. aureus. Tigecycline was slightly more active against Enterococcus faecium (MIC50/90, 0.03/0.06âmg/L) compared with Enterococcus faecalis (MIC50/90, 0.06/0.12âmg/L) and its activity was not adversely affected by vancomycin resistance when tested against these organisms. Tigecycline potency was comparable for Streptococcus pneumoniae (MIC50/90, 0.03/0.06âmg/L), viridans group streptococci (MIC50/90, 0.03/0.06âmg/L) and β-haemolytic streptococci (MIC50/90, 0.06/0.06âmg/L) regardless of species and penicillin susceptibility. Tigecycline was active against Enterobacteriaceae (MIC50/90, 0.25/1âmg/L; 97.8% inhibited at â¤2âmg/L) but was slightly less active against Enterobacteriaceae isolates expressing resistant phenotypes: carbapenem-resistant Enterobacteriaceae (MIC50/90, 0.5/2âmg/L; 98.0% susceptible); multidrug-resistant (MIC50/90, 0.5/2âmg/L; 93.1% susceptible); and extensively drug-resistant (MIC50/90, 0.5/4âmg/L; 87.8% susceptible). Tigecycline inhibited 74.4% of 888 Acinetobacter baumannii isolates at â¤2âmg/L (MIC50/90, 2/4âmg/L) and demonstrated good in vitro activity against Stenotrophomonas maltophilia (MIC50/90, 1/2âmg/L; 90.6% inhibited at â¤2âmg/L) Tigecycline was active against Haemophilus influenzae (MIC50/90, 0.12/0.25âmg/L) regardless of β-lactamase status. Tigecycline represents an important treatment option for resistant Gram-negative and Gram-positive bacterial infections.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Antimicrobial Agents - Volume 51, Issue 6, June 2018, Pages 848-853
Journal: International Journal of Antimicrobial Agents - Volume 51, Issue 6, June 2018, Pages 848-853
نویسندگان
Michael A. Pfaller, Michael D. Huband, Jennifer M. Streit, Robert K. Flamm, Helio S. Sader,